Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies
Ángela‐Patricia Hernández, Pablo Juanes‐Velasco, Alicia Landeira‐Viñuela, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2821-2821
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 612
Cancer vaccines: Building a bridge over troubled waters
MacLean C. Sellars, Catherine J. Wu, Edward F. Fritsch
Cell (2022) Vol. 185, Iss. 15, pp. 2770-2788
Open Access | Times Cited: 197
Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade
Zhiyu Zhao, Shuming Dong, Yue Liu, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20400-20418
Closed Access | Times Cited: 90
Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment
Salar Hafez Ghoran, Andrea Calcaterra, Milad Abbasi, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5236-5236
Open Access | Times Cited: 75
Photosensitizer Nanodot Eliciting Immunogenicity for Photo‐Immunologic Therapy of Postoperative Methicillin‐Resistant Staphylococcus aureus Infection and Secondary Recurrence
Haozheng Tang, Xinhua Qu, Wenkai Zhang, et al.
Advanced Materials (2021) Vol. 34, Iss. 12
Closed Access | Times Cited: 79
Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials
Dhananjay Yadav, Minseok Kwak, Pallavi Chauhan, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 909-922
Closed Access | Times Cited: 45
Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation
Hajra Zafar, Jun Zhang, Faisal Raza, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 446-466
Closed Access | Times Cited: 10
Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer
Liyun Zheng, Yiming Ding, Shiji Fang, et al.
ACS Nano (2024) Vol. 18, Iss. 40, pp. 27597-27616
Closed Access | Times Cited: 9
Integrin‐Targeted, Activatable Nanophototherapeutics for Immune Modulation: Enhancing Photoimmunotherapy Efficacy in Prostate Cancer Through Macrophage Reprogramming
Cheng Zhang, Xiaolan Yin, Lei Hao, et al.
Aggregate (2025)
Open Access | Times Cited: 1
Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It
Cong Chen, Qianwei Ye, Linbo Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Autophagy and cancer therapy
Julio Pimentel, Jun Zhou, Gen Sheng Wu
Cancer Letters (2024) Vol. 605, pp. 217285-217285
Closed Access | Times Cited: 6
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS
Pablo Juanes‐Velasco, Alicia Landeira‐Viñuela, Marina L. García‐Vaquero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
Jinguo Zhang, Shuaikang Pan, Jian Chen, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products
Lele Zhang, Du-Juan Zhang, Jia-Xin Shi, et al.
Phytomedicine (2024) Vol. 132, pp. 155828-155828
Closed Access | Times Cited: 6
Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
Zhicheng Jin, Xuefeng Sun, Yaoyao Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Valeria Lucarini, Ombretta Melaiu, Silvia D’Amico, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Monoclonal antibodies as adjuvant therapies for resected melanoma
Islam Eljilany, Julita García, Basem T. Jamal, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-14
Closed Access
Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy
Y. Engelen, Robin Demuynck, Jan Ramon, et al.
Journal of Controlled Release (2025), pp. 113721-113721
Closed Access
Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review)
Wei Liang, Xinying He, Jianqiang Bi, et al.
Oncology Reports (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 21
Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages
Cheng‐Peng Sun, Jianhao Zhan, Yao Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 3
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3
Bernardo L. Rapoport, Helen C. Steel, Carol Benn, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies
Maria D. Fenor de la Maza, Guillermo Villacampa, B. Miñana, et al.
Clinical Genitourinary Cancer (2023) Vol. 22, Iss. 2, pp. 330-335
Closed Access | Times Cited: 7
Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma
Shuai Han, Qinghe Wang, Mingquan Shen, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27630-e27630
Open Access | Times Cited: 2
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field
Islam Eljilany, Ella Castellano, Ahmad A. Tarhini
Cancers (2023) Vol. 15, Iss. 16, pp. 4125-4125
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top